Please ensure Javascript is enabled for purposes of website accessibility

Why Intuitive Surgical Stock Just Dropped

By Rich Smith - Jan 22, 2021 at 11:26AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Earnings grew, but maybe less than was hoped.

What happened

A little over a week after preannouncing sales for Q4 and full-year 2020 (which sent the stock up), robotic surgery specialist Intuitive Surgical (ISRG -4.37%) released its full earnings results last night -- which sent the stock down.

Despite beating earnings expectations, as of 10:40 a.m. EST, Intuitive Surgical stock has fallen 5.5%.

Blackboard drawing of stock chart altered to point down instead of up.

Image source: Getty Images.

So what

We already knew (from the preannouncement) that Q4 sales had exceeded expectations -- $1.33 billion versus a consensus target of $1.23 billion. Last night, Intuitive Surgical confirmed that earnings were also better than expected. Analysts had predicted that Intuitive would earn $3.12 per share in Q4, but the company earned $3.58 per share (pro forma) instead.

When calculated according to generally accepted accounting principles (GAAP), Intuitive's profits weren't as great as that pro forma number, but Intuitive still earned $3.02, which was 1% better than in last year's Q4.

Analysts seem to like that number, with about five different investment banks raising their price targets on Intuitive Surgical stock in response to the news. Still, it was a bit disappointing to see sales at the company grow 4% (as preannounced), but earnings grow only 1% (as just announced).  

Now what

Honestly, I suspect this is the reason investors are selling off Intuitive Surgical stock this morning: They were hoping that the company's earnings beat would dwarf the size of its sales beat, and that didn't happen. But this doesn't mean the news was bad.

In the face of a global pandemic that squelched elective medical procedures as hospitals devoted their attention to fighting the novel coronavirus, Intuitive Surgical still managed to increase its procedure volume by 6% in Q4 and 1% for the year.

Yes, management is warning that the ongoing pandemic "will likely continue to have ... an adverse impact on the Company's procedure volumes." But eventually this pandemic will end. Eventually this recession will end. Once things get back to "normal," there will be a huge amount of backlogged procedures and pent-up demand for medical services to work through.

I expect that demand to benefit Intuitive Surgical -- and the investors who stick with the stock.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Intuitive Surgical, Inc. Stock Quote
Intuitive Surgical, Inc.
ISRG
$215.35 (-4.37%) $-9.83

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
349%
 
S&P 500 Returns
122%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/18/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.